Hemostatic efficacy of a fibrin sealant–based topical agent in a femoral artery injury model: A randomized, blinded, placebo-controlled study Mark R. Jackson, MD, Stanley A. Friedman, PhD, Andrew J. Carter, DO, Vladislav Bayer, BS, J.Robert Burge, MS, Martin J. MacPhee, PhD, William N. Drohan, PhD, Barbara M. Alving, MD Journal of Vascular Surgery Volume 26, Issue 2, Pages 274-280 (August 1997) DOI: 10.1016/S0741-5214(97)70189-7 Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North America Chapter Terms and Conditions
Fig. 1 Boxplots26 of blood loss from the fibrin sealant–treated artery and the control artery. The top of the box is the third quartile (Q3), and the bottom of the box is the first quartile (Q1). The horizontal line through the box represents the median. The vertical lines extend from the box to the adjacent values. The adjacent values are the lowest and highest observations that are still inside the region defined by the following limits: lower limit: Q1 – 1.5 (Q3 – Q1); upper limit: Q3 + 1.5 (Q3 – Q1). Outliers are points outside of the lower and upper limits and are marked by asterisks (*). Journal of Vascular Surgery 1997 26, 274-280DOI: (10.1016/S0741-5214(97)70189-7) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North America Chapter Terms and Conditions
Fig. 2 Femoral artery blood flow measured distal to the site of vessel injury for both groups. Journal of Vascular Surgery 1997 26, 274-280DOI: (10.1016/S0741-5214(97)70189-7) Copyright © 1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North America Chapter Terms and Conditions